date:Feb 27, 2014
atural Resources.
To McQuate, FDAs actions with regard to PHOs reflect diligence as well as a systematic process. He explains that safety determinations are not cut and dried. For example, unlike a straightforward test for the acidity of a solution, safety determinations require scientists to analyze an accumulation of information in a lot of different areas. That information is not easily deciphered and requires professional judgment calls, he says.
But, timing aside, some have questioned FDA